Stock 0G8X IMMUNOVIA AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Immunovia AB London S.E.

Equities

0G8X

SE0006091997

Market Closed - London S.E.
Other stock markets
 10:13:42 21/03/2024 GMT 		After market 15:27:11
1.4 SEK -96.26% Intraday chart for Immunovia AB 1.56 +11.43%
04-29 Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024
04-29 Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Immunovia AB, Q1 2024 Earnings Call, Apr 29, 2024
Immunovia appoints Dr. Lisa Ford as Clinical Laboratory Director
AQ
Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina
AQ
Immunovia Streamlines Lab Operations with Move to Research Triangle Park, North Carolina
CI
Immunovia Appoints Lisa Ford as Clinical Laboratory Director
CI
Immunovia publishes the annual report for 2023
AQ
Immunovia Publishes Interim Report for January-March 2024
AQ
Immunovia AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Invitation to Immunovia's Q1 presentation
AQ
Immunovia announces updated financial calendar
AQ
Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
AQ
Immunovia AB Announces Positive Results from the Model-Development Study for Its Next-Generation Pancreatic Cancer Detection Test
CI
Immunovia, Proteomedix Create Assays for Pancreatic Cancer Detection Test
MT
Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study
AQ
Immunovia Successfully Develops Assays to Measure Targeted Proteomedix for Its Next-Generation Pancreatic Cancer Test - Moving Forward Towards Model-Development Study
CI
Immunovia announces updated financial calendar
AQ
Transcript : Immunovia AB, 2023 Earnings Call, Feb 21, 2024
Immunovia Publishes Full Year Report for 2023
AQ
Immunovia AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Immunovia AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMMNOV Stock
  4. 0G8X Stock
  5. News Immunovia AB